APA
AVXL icon

American Portfolios Advisors’s Anavex Life Sciences AVXL Stock Holding History

American Portfolios Advisors’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$63K Hold
6,100
– – ﹤0.01% 1577
2022
Q2 		$61.1K Hold
6,100
– – ﹤0.01% 1653
2022
Q1 		$75.1K Buy
6,100
+600
+11% +$7.38K ﹤0.01% 1680
2021
Q4 		$95.4K Hold
5,500
– – ﹤0.01% 1536
2021
Q3 		$98.7K Hold
5,500
– – ﹤0.01% 1460
2021
Q2 		$126K Buy
+5,500
New +$81.5K ﹤0.01% 1320

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

American Portfolios Advisors's AVXL Position: Q3 2022 in Review

American Portfolios Advisors held its Anavex Life Sciences (AVXL) position steady in Q3 2022 at 6,100 shares worth $63K. The position accounts for ﹤0.01% of the portfolio, ranked #1577.

American Portfolios Advisors first reported a position in AVXL in Q2 2021 and has held it in 6 quarters since. The position peaked at $126K in Q2 2021. 147 funds tracked by Wall St. Rank hold AVXL as of Q3 2022.

  • American Portfolios Advisors held 6,100 shares of Anavex Life Sciences worth $63K as of Q3 2022.
  • American Portfolios Advisors left its Anavex Life Sciences share count unchanged in Q3 2022.
  • Anavex Life Sciences made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #1577 holding.
  • American Portfolios Advisors first reported a position in Anavex Life Sciences in Q2 2021 and has held it in 6 quarters since.
  • American Portfolios Advisors's Anavex Life Sciences position peaked at $126K in Q2 2021.
  • 147 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.